Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Anemia Is Negatively Correlated with Cardiac Index in Hereditary Hemorrhagic Telangiectasia(HHT) Patients with Liver Arteriovascular Malformations (AVMs)

Hafsa Farooq, MBBS, MD, Alfred I Lee, MD PhD, Lawrence Young, Katharine Henderson

Blood (2019) 134 (Supplement_1): 4811.

https://doi.org/10.1182/blood-2019-129555

Published: 2019

Journal Articles

Pomalidomide Reduces Bleeding and Alters Expression of Angiogenesis-Related Proteins in Patients with Hereditary Hemorrhagic Telangiectasia

Shadi Swaidani, MD PhD, Suman Kundu, MBA, Mohamed Samour, MBBS, Bernard Silver, MD, Joseph Parambil, MD, Sonia Thomas, DrPH, Keith R McCrae, MD

Blood (2019) 134 (Supplement_1): 5761.

https://doi.org/10.1182/blood-2019-127344

Published: 2019

Journal Articles

An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

Hanny Al-Samkari, MD, Raj S. Kasthuri, MD, Hasan A. Albitar, MD, Yahya Almodallal, MBBS, Marcelo M. Serra, MD, Carolina Vazquez, MD, Sophie Dupuis-Girod, MD PhD, Clifford R. Weiss, MD, Muhammad A. Latif, MD, Mary Elizabeth Meek, MD, David J. Kuter, Vivek N. Iyer, MD MPH

Blood (2019) 134 (Supplement_1): 1060.

https://doi.org/10.1182/blood-2019-129418

Published: 2019

Journal Articles

Incidence of Thromboembolic Disease in Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Marcelo Martin Serra, MD, Cristina Maria Elizondo, MD, Marina Alonso, MD, Veronica Peuchot, MD, Fernando Javier Vazquez, PhD

Blood (2018) 132 (Supplement 1): 4967.

https://doi.org/10.1182/blood-2018-99-112945

Published: 2018

Journal Articles

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Hanny Al-Samkari, MD, Athena Kritharis, MD, Josanna Rodriguez-Lopez, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 852.

https://doi.org/10.1182/blood-2018-99-117144

Published: 2018

Journal Articles

Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia

Kristy Pahl, MD, Arkopal Choudhury, Raj S. Kasthuri, MD MBBS

Blood (2016) 128 (22): 3776.

https://doi.org/10.1182/blood.V128.22.3776.3776

Published: 2016

Journal Articles

Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study

Mohamed Samour, MBBS, Caner Saygin, MD, Rashid Abdallah, RN, Suman Kundu, MS, MBA, Keith R. McCrae, MD

Blood (2016) 128 (22): 210.

https://doi.org/10.1182/blood.V128.22.210.210

Published: 2016

Journal Articles

Telehematology: Expanding Comprehensive Care for Pediatric Patients with Blood Disorders through Telemedicine at Several Delivery Sites (Medical Homes, Hospital Clinics, Home Setting and Hemophilia Treatment Centers (HTC)) and with Interdisciplinary Providers

Roshni Kulkarni, Laura Carlson, RN, Rebecca A Malouin, Ph. D.,M.S, M.P.H, Marcia L Bird, LMSW, Colleen Vallad-Hix, Michelle Witkop, DNP, FNP-BC, Ajovi Scott-Emuakpor, MDPhD, Renuka Gera, MD, Steve Gualdoni, PA

Blood (2015) 126 (23): 5576.

https://doi.org/10.1182/blood.V126.23.5576.5576

Published: 2015

Journal Articles

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

Joan Beckman, MDPhD, Karen L Smith, BS, Samuel T Hester, MD, Ofri Leitner, MS, CGC, Raj S. Kasthuri, MD MBBS

Blood (2014) 124 (21): 1515.

https://doi.org/10.1182/blood.V124.21.1515.1515

Published: 2014

Journal Articles

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Mansoor Radwi, MD, Arjuna Ponnampalam, MD, Marie E Faughnan, MD, Nadine Shehata, MD, MSC

Blood (2013) 122 (21): 4745.

https://doi.org/10.1182/blood.V122.21.4745.4745

Published: 2013

Journal Articles

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

Carlo L Balduini, Francesca Bellistri, Fabio Pagella, Francesco Chu, Elina Matti, Giuseppe Spinozzi, Federica Ornati, Cecilia Canzonieri, Carla Olivieri, Cesare Danesino, Marco Benazzo, Rosangela Invernizzi

Blood (2012) 120 (21): 629.

https://doi.org/10.1182/blood.V120.21.629.629

Published: 2012

Journal Articles

Hereditary Haemorrhagic Telangiectasia Spectrum of ALK1/ENG Mutation

Giorgio Corinaldesi, MD, PhD

Blood (2010) 116 (21): 5066.

https://doi.org/10.1182/blood.V116.21.5066.5066

Published: 2010

Journal Articles

Bevacizumab Rapidly and Completely Corrects Massive Transfusion Requirement In a Patient with Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Donald Busiek, MD, Keith Bernstein, M.D.

Blood (2010) 116 (21): 2118.

https://doi.org/10.1182/blood.V116.21.2118.2118

Published: 2010

Journal Articles

Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations

Nicolas Ricard, Marie Bidart, Christine Mallet, Gaetan Lesca, Sophie Giraud, Renaud Prudent, Jean-Jacques Feige, Sabine Bailly

Blood (2010) 116 (9): 1604–1612.

https://doi.org/10.1182/blood-2010-03-276881

Published: 2010

Journal Articles

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Prithviraj Bose, MD, Jennifer Holter, MD, George Selby, MD

Blood (2008) 112 (11): 3928.

https://doi.org/10.1182/blood.V112.11.3928.3928

Published: 2008

Journal Articles

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

Antonios Kattamis, MD, Christina Lazaropoulou, BSc, Maria Siopi, BSc, Ino Kanavaki, MD, Evgenios Goussetis, MD, Vassilios Ladis, MD, Ioannis Papassotiriou, PhD

Blood (2008) 112 (11): 5408.

https://doi.org/10.1182/blood.V112.11.5408.5408

Published: 2008

Journal Articles

ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2

Sung O. Park, Young Jae Lee, Tsugio Seki, Kwon-Ho Hong, Naime Fliess, Zhigang Jiang, Alice Park, Xiaofang Wu, Vesa Kaartinen, Beth L. Roman, S. Paul Oh

Blood (2008) 111 (2): 633–642.

https://doi.org/10.1182/blood-2007-08-107359

Published: 2008

Includes: Supplemental data

Journal Articles

Thalidomide for the Treatment of Chronic Bleeding Secondary to Hereditary Hemorrhagic Telangiectasia and Gastrointestinal Vascular Malformations.

Marion B. Raflores, MD, Richard K. Shadduck, MD

Blood (2006) 108 (11): 3927.

https://doi.org/10.1182/blood.V108.11.3927.3927

Published: 2006

Journal Articles

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

Laurent David, Christine Mallet, Sabine Mazerbourg, Jean-Jacques Feige, Sabine Bailly

Blood (2006) 109 (5): 1953–1961.

https://doi.org/10.1182/blood-2006-07-034124

Published: 2006

Journal Articles

Management of Recurring Epistaxis in Hereditary Hemorrhagic Teleangectasia.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2005) 106 (11): 4061.

https://doi.org/10.1182/blood.V106.11.4061.4061

Published: 2005

NARROW

Anemia Is Negatively Correlated with Cardiac Index in Hereditary Hemorrhagic Telangiectasia(HHT) Patients with Liver Arteriovascular Malformations (AVMs)

Pomalidomide Reduces Bleeding and Alters Expression of Angiogenesis-Related Proteins in Patients with Hereditary Hemorrhagic Telangiectasia

An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

Incidence of Thromboembolic Disease in Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia

Pomalidomide in Hereditary Hemorrhagic Telangiectasia: Interim Results of a Phase I Study

Telehematology: Expanding Comprehensive Care for Pediatric Patients with Blood Disorders through Telemedicine at Several Delivery Sites (Medical Homes, Hospital Clinics, Home Setting and Hemophilia Treatment Centers (HTC)) and with Interdisciplinary Providers

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

Hereditary Haemorrhagic Telangiectasia Spectrum of ALK1/ENG Mutation

Bevacizumab Rapidly and Completely Corrects Massive Transfusion Requirement In a Patient with Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations

Use of Bevacizumab in Hereditary Hemorrhagic Telangiectasia

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2

Thalidomide for the Treatment of Chronic Bleeding Secondary to Hereditary Hemorrhagic Telangiectasia and Gastrointestinal Vascular Malformations.

Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells

Management of Recurring Epistaxis in Hereditary Hemorrhagic Teleangectasia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only